The Editor's Roundtable: Intracoronary Hyperoxemic Therapy in Acute Myocardial Infarction

      This CME activity is supported by an educational grant from TherOx, Inc., Palo Alto, California.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Spears R.J.
        • Wang B.
        • Wu X.
        • Prcevski P.
        • Jiang A.J.
        • Spanta A.D.
        • Crilly R.J.
        • Brereton G.J.
        Aqueous oxygen: a highly O2-supersaturated infusate for regional correction of hypoxemia and production of hyperoxemia.
        Circulation. 1997; 96: 4385-4391
        • O'Neill W.W.
        • Martin J.L.
        • Dixon S.R.
        • Bartorelli A.L.
        • Trabattoni D.
        • Oemrawsingh P.V.
        • Atsma D.E.
        • Chang M.
        • Marquardt W.
        • Oh J.K.
        • Krucoff M.W.
        • Gibbons R.J.
        • Spears J.R.
        • AMIHOT Investigators
        Acute Myocardial Infarction With Hyperoxemic Therapy (AMIHOT): a prospective, randomized trial of intracoronary hyperoxemic reperfusion after percutaneous coronary intervention.
        J Am Coll Cardiol. 2007; 50: 397-405
        • Walker G.
        TIMI risk score for UA/NSTEMI.
        (Accessed May 1, 2009)
        • Miller T.D.
        • Christian T.F.
        • Hopfenspirger M.R.
        • Hodge D.O.
        • Gersh B.J.
        • Gibbons R.J.
        Infarct size after acute myocardial infarction measured by quantitative tomographic 99mTc-sestamibi imaging predicts subsequent mortality.
        Circulation. 1995; 92: 334-341
        • Gibbons R.J.
        • Miller T.D.
        • Christian T.F.
        Infarct size measured by single photon emission computed tomographic imaging with (99m) Tc-sestamibi: a measure of the efficacy of therapy in acute myocardial infarction.
        Circulation. 2000; 101: 101-108
        • Medrano R.
        • Lowry R.W.
        • Young J.B.
        • Weilbaecher D.G.
        • Michael L.H.
        • Afridi I.
        • He Z.-X.
        • Mahmarian J.J.
        • Verani M.S.
        Assessment of myocardial viability with 99mTc sestamibi in patients undergoing cardiac transplantation.
        Circulation. 1996; 94: 1010-1017
        • Schomig A.
        • Kastrati A.
        • Dirschinger J.
        • Mehilli J.
        • Schricke U.
        • Pache J.
        • Martinoff S.
        • Neumann F.
        • Schwaiger M.
        • Stent Versus Thrombolysis for Occluded Coronary Arteries in Patients With Acute Myocardial Infarction Study Investigators
        Coronary stenting plus platelet glycoprotein IIb/IIIa blockage compared with tissue plasminogen activator in acute myocardial infarction.
        N Engl J Med. 2000; 343: 385-391
        • The GUSTO Investigators
        An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction.
        Circulation. 1993; 329: 673-682